ARTICLEArticles

2022.11.30

Cost-consequence of abatacept as first-line therapy in Japanese rheumatoid arthritis patients using IORRA real-world data.

  • Language
    English
  • Year and Month of Publication/Presentation
    01/11/2022
  • Type of Article
    Original Article
  • Invited Article
    Not Applicable
  • Journal Name
    PLoS One
  • Publication Classification
    Academic Journal
  • Publisher / Organization
    Public Library of Science
  • Volume, Issue,
    Page Numbers
    Vol. 7, No. 11, p. 17
  • Total Pages
    -
  • Author Contribution
    Co-authors
  • Authors and Co-authors
    Tanaka E, Inoue E, Shoji A, Nilsson J, Papagiannopoulos C, Dhanda D, Yoshizawa Y, Abe M, Saka K, Sugano E, Sugitani N, Ochiai M, Yamaguchi R, Ikari K, Yamanaka H, Harigai M
PAGE TOP ↑